All In MedTech

FDA Clearance Tracker · P970004-S292

InterStim Therapy System and Verify Evaluation System (SNS Urinary)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 19, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 19, 2020

Approved

Time to decision

254 days

Received Jun 10, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970004-S292
Device name
InterStim Therapy System and Verify Evaluation System (SNS Urinary)
Applicant location
Minneapolis, MN
Received
Jun 10, 2019
Decided
Feb 19, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970004

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval for the implementation of new components and kit configurations.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.